2002

Nov 15, 2002
Guidant to Highlight New Advances in Heart Failure Management During 75th Scientific Sessions of the American Heart Association

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it is providing support for a special Continuing...

Nov 15, 2002
Guidant Appoints Joseph M. Smith, M.D., Ph.D. as Chief Medical Officer for Cardiac Rhythm Management

Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Joseph M. Smith, M.D., Ph.D....

Nov 14, 2002
New National Registry Will Study Left Ventricular Dysfunction in 100,000 Patients

Scientific data-gathering effort will provide meaningful information on a cardiac condition that precedes or accompanies serious heart disease such as heart failure Indianapolis, Ind. and St....

Nov 13, 2002
Guidant and Genzyme Announce Cross-License Agreement

Deal Demonstrates Guidant's Commitment to Innovation and Intellectual Property Indianapolis, Ind. and Cambridge, Mass. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Nov 13, 2002
Guidant to Participate in the Credit Suisse First Boston Health Care Conference

Live Webcast Available Indianapolis, Ind - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the...

Show 5102550100 per page
Top